As the overall level of convergence between industries in the business world keeps increasing, it is only logical for the related legal aspects to follow suit every step of the way.

The last year saw a number of adverse legal changes for the innovative life sciences industry in Europe. This article looks at a number of these recent changes and asks whether the news really is all bad.

Pharmaceutical and Medical Device Regulation Comparative Guide for the jurisdiction of Serbia, check out our comparative guides section to compare across multiple countries.